A citation-based method for searching scientific literature

Young Shin Song, Young Joo Park. Endocrinol Metab (Seoul) 2020
Times Cited: 3







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
549
100

BRAF mutation in thyroid cancer.
M Xing. Endocr Relat Cancer 2005
906
100

Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, Lewis Hassell. Clin Endocrinol (Oxf) 2017
50
66

Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
Shinje Moon, Young Shin Song, Ye An Kim, Jung Ah Lim, Sun Wook Cho, Jae Hoon Moon, Seokyung Hahn, Do Joon Park, Young Joo Park. Thyroid 2017
68
66

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
390
66

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
Mingzhao Xing, William H Westra, Ralph P Tufano, Yoram Cohen, Eli Rosenbaum, Kerry J Rhoden, Kathryn A Carson, Vasily Vasko, Alexandr Larin, Giovanni Tallini,[...]. J Clin Endocrinol Metab 2005
696
66



Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
Seo Ki Kim, Jung-Woo Woo, Jun Ho Lee, Inhye Park, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim. Surgery 2015
27
33

Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis.
Jing-Yong Song, Shi-Ran Sun, Fang Dong, Tao Huang, Bin Wu, Jing Zhou. Curr Med Sci 2018
9
33

Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.
Aldona Kowalska, Agnieszka Walczyk, Artur Kowalik, Iwona Pałyga, Tomasz Trybek, Janusz Kopczyński, Maciej Kajor, Magdalena Chrapek, Liliana Pięciak, Małgorzata Chłopek,[...]. Thyroid 2016
21
33


Thyroid cancer epidemiology and prognostic variables.
J A Sipos, E L Mazzaferri. Clin Oncol (R Coll Radiol) 2010
324
33


Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.
Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee. Cancer Res Treat 2018
268
33

Telomerase RNA biosynthesis and processing.
E M Smekalova, O S Shubernetskaya, M I Zvereva, E V Gromenko, M P Rubtsova, O A Dontsova. Biochemistry (Mosc) 2012
26
33

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
33

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
33


Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans.
Sue Youn Kim, Taeeun Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Chan Kwon Jung. J Pathol Transl Med 2020
7
33

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, Tomoe Nakao, Kosho Yamanouchi, Chika Sakimura, Hiroshi Yano, Eijun Nishihara, Mitsuyoshi Hirokawa, Keiji Suzuki,[...]. Thyroid 2019
18
33

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
33

Heterogeneity of Thyroid Cancer.
Ewa Chmielik, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Michal Jarzab, Jolanta Krajewska, Agnieszka Czarniecka, Barbara Jarzab. Pathobiology 2018
41
33

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park,[...]. Cancer 2016
91
33

BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.
Avik Chakraborty, Archana Narkar, Rita Mukhopadhyaya, Shubhada Kane, Anil D'Cruz, M G R Rajan. Endocr Pathol 2012
53
33

Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
Pierpaolo Trimboli, Lorenzo Scappaticcio, Giorgio Treglia, Leo Guidobaldi, Massimo Bongiovanni, Luca Giovanella. Endocr Pathol 2020
5
33


Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis.
Tomomi Yamaguchi, Toshiaki Akahane, Ohi Harada, Yasutaka Kato, Eriko Aimono, Hidehiro Takei, Takashi Tasaki, Hirotsugu Noguchi, Hiroshi Nishihara, Hajime Kamata,[...]. Diagn Cytopathol 2020
5
33

Molecular genetics and diagnosis of thyroid cancer.
Yuri E Nikiforov, Marina N Nikiforova. Nat Rev Endocrinol 2011
576
33

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.
Efisio Puxeddu, Sonia Moretti, Rossella Elisei, Cristina Romei, Raffaela Pascucci, Marco Martinelli, Cecilia Marino, Nicola Avenia, Esther Diana Rossi, Guido Fadda,[...]. J Clin Endocrinol Metab 2004
213
33

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
183
33

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
74
33


Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: a cytohistologic institutional experience.
Esther Diana Rossi, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Patrizia Straccia, Basilio Angrisani, Costantino Ricci, Paola Lanza, Celestino Pio Lombardi, Alfredo Pontecorvi,[...]. Cancer Cytopathol 2014
36
33

Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.
Guido Fadda, Esther Diana Rossi, Marco Raffaelli, Alfredo Pontecorvi, Stefano Sioletic, Francesca Morassi, Celestino Pio Lombardi, Gian Franco Zannoni, Guido Rindi. Eur J Endocrinol 2011
73
33

Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region.
Chih-Yi Liu, Andrey Bychkov, Shipra Agarwal, Yun Zhu, Jen-Fan Hang, Chiung-Ru Lai, Hee Young Na, Weiwei Li, Zhiyan Liu, Deepali Jain,[...]. Diagn Cytopathol 2021
3
33

Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Huy Gia Vuong, Ahmed Ma Altibi, Uyen Np Duong, Hanh Tt Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell,[...]. Tumour Biol 2017
24
33

Italian consensus for the classification and reporting of thyroid cytology.
Francesco Nardi, Fulvio Basolo, Anna Crescenzi, Guido Fadda, Andrea Frasoldati, Fabio Orlandi, Lucio Palombini, Enrico Papini, Michele Zini, Alfredo Pontecorvi,[...]. J Endocrinol Invest 2014
201
33

Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules.
E D Rossi, M Martini, S Capodimonti, T Cenci, M Bilotta, F Pierconti, A Pontecorvi, C P Lombardi, G Fadda, L M Larocca. Cytopathology 2018
8
33

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
L Fugazzola, E Puxeddu, N Avenia, C Romei, V Cirello, A Cavaliere, P Faviana, D Mannavola, S Moretti, S Rossi,[...]. Endocr Relat Cancer 2006
186
33

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Young Shin Song, Seong-Keun Yoo, Hwan Hee Kim, Gyeongseo Jung, Ah-Reum Oh, Ji-Young Cha, Su-Jin Kim, Sun Wook Cho, Kyu Eun Lee, Jeong-Sun Seo,[...]. Endocr Relat Cancer 2019
25
33

Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.
Gabriella Pellegriti, Francesco Frasca, Concetto Regalbuto, Sebastiano Squatrito, Riccardo Vigneri. J Cancer Epidemiol 2013
671
33

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
370
33


BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
Esther Diana Rossi, Maurizio Martini, Sara Capodimonti, Celestino Pio Lombardi, Alfredo Pontecorvi, Valerio Gaetano Vellone, Gian Franco Zannoni, Luigi Maria Larocca, Guido Fadda. Cancer Cytopathol 2013
85
33

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
183
33

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, Jung Hyun Yang. Thyroid 2016
42
33

Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience.
Esther Diana Rossi, Tommaso Bizzarro, Maurizio Martini, Sara Capodimonti, Guido Fadda, Luigi Maria Larocca, Fernando Schmitt. Cancer Cytopathol 2014
27
33

TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Greta Gandolfi, Moira Ragazzi, Andrea Frasoldati, Simonetta Piana, Alessia Ciarrocchi, Valentina Sancisi. Eur J Endocrinol 2015
79
33

Preoperative Assessment of TERT Promoter Mutation on Thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy.
A Crescenzi, P Trimboli, D C Modica, C Taffon, L Guidobaldi, S Taccogna, A Rainer, M Trombetta, E Papini, G Zelano. Horm Metab Res 2016
23
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.